FDA classifies Medtronic tissue stabilizer recall as Class I

The FDA has classified the Medtronic's previous action related to the Octopus Nuvo tissue stabilizer, which is used to stabilize tissue during certain surgical procedures, as a Class I recall. The agency classifies a recall as Class I when it believes there is a reasonable probability that use of the recalled product will cause serious adverse health consequences.

Medtronic voluntarily recalled the device from the market Sept. 14 because a component could fracture during use, potentially resulting in fragments falling into the patient's chest cavity and/or damaging the heart tissue. Medtronic has received two reports of device failure occurring during patient use, which required retrieval of device fragments from the surgical wound; neither event resulted in permanent impairment or death, according to a company statement. 

"There are no reports of any adverse effects, of any illness or any injury to any patients," says Kathleen Janasz, a Medtronic spokeswoman, according to Minnesota Public Radio. "All of the health care facilities that purchased it have been notified. Health care facilities just need to return the device."

- see the Medtronic statement
- get more from MPR
-
check out the Reuters report

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.